Invasive mole in a perimenopausal woman with lung and vaginal metastases: A case report
Entity
UAM. Departamento de Medicina; UAM. Departamento de Obstetricia y Ginecología; Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD)Publisher
John Wiley & Sons Ltd.Date
2019Citation
10.1002/ccr3.2386
Clinical Case Reports 7 (2019): 2300–2305
ISSN
2050-0904DOI
10.1002/ccr3.2386Editor's Version
https ://doi.org/10.1002/ccr3.2386Subjects
Gestational trophoblastic neoplasia; Hysterectomy; Invasive mole; Metastases; Perimenopausal; Trophoblastic disease; MedicinaRights
© 2019 The AuthorsAbstract
Gestational trophoblastic disease can result in serious complications and disease progression.
Therefore, follow‐up of such patients is essential for early detection of
malignant trophoblastic tumors and to reduce mortality rate. Primary treatment is
chemotherapy but hysterectomy should be considered in patients who have uncontrollable
hemorrhage and hemodynamic instability
Files in this item
Google Scholar:Martínez Leocadio, Cristina
-
García Villayzán, José
-
García‐Foncillas López, Jesús
-
Idrovo, Franklin
-
Plaza Arranz, Javier
-
Albi González, Manuel
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer
Aguilera, Óscar; González Sancho, José Manuel; Zazo, Sandra; Rincón, Raúl; Fernández, Agustín F.; Tapia, Olga; Canals, Francesc; Morte, Beatriz; Calvanese, Vincenzo; Orgaz, José Luis; Niell, Núria; Aguilar, Susana; Freije, José M.; Graña, Osvaldo; Pisano, David G.; Borrero, Aúrea; Martínez-Useros, Javier; Jiménez Cuenca, Benilde; Fraga, Mario F.; García-Foncillas López, Jesús Miguel; López-Otín, Carlos; Lafarga, Miguel; Rojo, Federico; Muñoz, Alberto
2015-02-28 -
Microrna-31 emerges as a predictive biomarker of pathological response and outcome in locally advanced rectal cancer
Caramés, Cristina; Cristobal, Ion; Moreno, Víctor; Marín, Juan P.; González-Alonso, Paula; Torrejón, Blanca; Minguez, Pablo; Leon, Ana; Martín, José I.; Hernández, Roberto; Pedregal, Manuel; Martín, María J.; Cortés, Delia; García Olmo, Damián; Fernández, María J.; Rojo, Federico; García-Foncillas López, Jesús Miguel
2016-06-01 -
Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer (Scientific Reports, (2019), 9, 1, (2589), 10.1038/s41598-019-39291-2)
Borrero-Palacios, A.; Cebrián, A.; Gómez del Pulgar, M. T.; García-Carbonero, R.; Garcia-Alfonso, P.; Aranda, E.; Elez, E.; López-López, R.; Cervantes, A.; Valladares, M.; Nadal, C.; Viéitez, J. M.; Guillén-Ponce, C.; Rodríguez, J.; Hernández, I.; García, J. L.; Vega-Bravo, R.; Puime-Otin, A.; Martínez-Useros, J.; Del Puerto-Nevado, L.; Rincón, R.; Rodríguez-Remírez, M.; Rojo, F.; García-Foncillas López, Jesús Miguel; Instituto de Investigación Sanitaria Fundación Jiménez Díaz (ISS-FJD)
2019-05-17